You equate an RTF on the BLA a success? Maybe in NP world.
FYI , Less than 4 % of drug filings get an RTF. NP is just so special.
The percentage of RTF’s are low because knowledgeable pharma executives listen to what the FDA tells them in crafting a BLA or pull it based on what they are being told during the review. Neither event occurred here, so illustrious leader NP evoked this “ special treatment “ for CYDY HIV BLA.
To be clear simply resubmitting the deficient dosing and RO info is not a milestone …. Maybe for NP, since he has no other achievements.